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Importance Single ventricle CHD affects about 5 out of 100,000 newborns, resulting in complex
anatomy often requiring multiple, staged palliative surgeries. Paediatricians are an essential part
of the team that cares for children with single ventricle CHD. These patients often encounter
their paediatrician first when a complication arises, so it is critical to ensure the paediatrician is
knowledgeable of these issues to provide optimal care. Observations We reviewed the subtypes
of single ventricle heart disease and the various palliative surgeries these patients undergo.
We then searched the literature to detail the general paediatrician’s approach to single ventricle
patients at different stages of surgical palliation. Conclusions and relevance Single ventricle patients undergo staged palliation that drastically changes physiology after each intervention. Coordinated care between their paediatrician and cardiologist is requisite to provide
excellent care. This review highlights what to expect when these patients are seen by their
paediatrician for either well child visits or additional visits for parental or patient concern.

Single ventricle CHD encompasses a wide variety of anatomic and subsequent treatment
sequelae. Single ventricle cardiac conditions include hypoplastic left heart syndrome, tricuspid
atresia, double inlet left ventricle, unbalanced atrioventricular canal defects, and hypoplastic
right heart lesions. Increasingly, these lesions are diagnosed prenatally, and standardised newborn CHD screening has helped improve outcomes.1–3 Children with single ventricle anatomy
and physiology are managed through a series of staged palliative interventions with the ultimate
goal of separating the pulmonary and systemic circulations.4 These interventions typically take
place immediately after birth and continue over the course of the child’s life. Children with
these conditions see their paediatrician and cardiologist frequently and, while there is much
information published about the importance of multi-disciplinary care and empowering caregivers, there is a dearth of information targeted specifically for their primary paediatric providers, especially following each palliative intervention.5 Care for these children requires a
coordinated approach between their cardiologist and paediatrician – to ensure they have an
effective medical home.
Overview of care for children with single ventricle physiology
1. Initial post-natal interventions (Norwood, Ductal Stent, Blalock-Taussig-Thomas
shunt, Pulmonary Artery Band)
All unpalliated single ventricle heart disease patients share the following physiologic characteristics. First, there is mixing of the systemic and pulmonary venous blood such that oxygen
saturation is 75–85%. Second, the single ventricle pumps blood to both the body and lungs
and thus is working harder than a biventricular circulation. This increased strain and decreased
reserve is the primary reason why children with unpalliated single ventricle physiology
are so fragile. And finally, the circulatory physiology is most stable when the systemic
and pulmonary blood flows are appropriately balanced (typically reflected by oxygen
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Figure 1. The anatomy of a hypoplastic right heart
with an underdeveloped right heart, with pulmonary
atresia and/or tricuspid atresia with a stent in the ductus
arteriosus (PDA stenting). RA= right atrium, RV = right
ventricle, PFO = patent foramen ovale, AO = aorta, LA
= left atrium, MV = mitral valve, LV = left ventricle,
LPA = left pulmonary artery. MPA = main pulmonary
artery.

saturations of 75–85%). Too much or too little flow to one
circuit places the child at risk of decompensation.
Depending on the cardiac anatomy, the first intervention for a
newborn with single ventricle anatomy focuses on establishing reliable and balanced sources of pulmonary and systemic flow. If the
native left ventricle and aorta are adequate, the infant usually
requires only a stable source of pulmonary blood flow, achieved
by placing either a stent in the ductus arteriosus or by surgically
placing an aorta-to-pulmonary artery shunt (e.g., BlalockTaussig-Thomas or central shunt) (Fig 1).
If the native left heart and/or aorta are inadequate (as in
hypoplastic left heart syndrome), a Norwood operation with
either a Blalock-Taussig-Thomas or Sano shunt (right ventricle
to pulmonary artery) is performed to establish adequate pulmonary and systemic blood flow (Fig 2). Infants often require a
prolonged recovery in the ICU and then cardiac ward. The
“Hybrid Stage 1” is another technique that involves placing a

ductus arteriosus stent for systemic blood flow and applying
bands to each pulmonary artery to balance the pulmonary
and systemic circulations.6 This procedure is done without
cardiopulmonary bypass, so some centres routinely perform it
while other utilise this technique for patients with significant
co-morbidities that may render them too fragile to undergo
the more extensive Norwood operation.6
Some newborns with single ventricle anatomy have adequate
systemic and pulmonary outflow tracts at birth, but only one
side is capable of pumping effectively (e.g., tricuspid valve atresia with a large ventricular septal defect and normal aortic/
pulmonary valves). As a result, these babies can have “unrestrictive” flow to their lungs which places them at risk for pulmonary
over-circulation and potentially inadequate systemic flow.
For these children, pulmonary blood flow needs to be restricted,
typically with a pulmonary artery band, to balance the systemic
and pulmonary circulations.
2. Interstage phase

Figure 2. Norwood operation diagram.
Stage 1 operation depicting the Norwood operation pulmonary blood flow being supplied by either a right ventricle (RV) to pulmonary artery conduit (Sano Shunt) or
Blalock-Taussig-Thomas (BTT) shunt from the innominate artery to the right pulmonary artery. RA = right atrium, RV = right ventricle, LA= left atrium, Neo-Ao = neo aorta,
MPA = main pulmonary artery
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Home monitoring
The “interstage” period between the first (when performed) and
second major operations typically lasts until 4–5 months of age
and is a time associated with significant morbidity and mortality.7
Those risks are related to the burden placed upon the single ventricle to maintain both the systemic and pulmonary circulations
after the initial palliation. So, infants in the interstage period are
often monitored closely by multi-disciplinary interstage teams,
which has led to improved outcomes.7–9 Home monitoring teams
closely follow numerous data points such as daily weight and oxygen saturation. Families remain in close contact with the home
monitoring team and are trained to identify markers of adverse
outcomes, such as oxygen saturations that are persistently out of
range (e.g., <75% or > 90%), feeding difficulties, or inadequate
weight gain among others.
In addition, interstage patients are seen frequently by their cardiologist, as often as every 1–2 weeks in the first months after hospital discharge. Visits may be scheduled to alternate with
paediatrician appointments, so that the infant is seen weekly.
Follow-up may be spaced to 2–4 weeks, depending on the team’s
assessment of the infant’s overall condition.10
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Feeding
Healthy growth is a crucial issue in the interstage period.11 These
infants may be discharged home with supplemental enteral feeds
or a nasogastric tube, depending upon swallow/feeding evaluations
and the infants’ ability to take adequate oral feeds. Some centres
prefer to place a surgical gastrostomy tube. Many interstage teams
include dieticians who optimise caloric intake and growth prior to
the next intervention. In addition, speech or occupational therapists may be consulted to improve oral motor skills.
Sternal Precautions and Wound Care
Most centres recommend sternal precautions for at least 6 weeks
after an operation requiring a sternotomy. Sternal precautions
include avoiding lifting the infant from under their arms since this
places stress on the healing sternum and can potentially lead to
sternal fracture and instability. Rather, infants should be lifted
in a cradle position, supporting their legs, back, neck, and head.
If signs of surgical site infection arise, the cardiologist and/or
cardiothoracic surgeon will want to be notified immediately.
Concerning findings include significant redness, warmth,
discharge, and fever without a source.
Medications Including Antithrombotics
Common cardiac medications include digoxin for infants with
hypoplastic left heart syndrome,12,13 angiotensin-converting
enzyme inhibitors for children with significant valve regurgitation
or ventricular dysfunction,14 and beta-blockers for infants with history of arrhythmia. Many infants are on a diuretic (e.g., furosemide) due to some degree of pulmonary over-circulation. The
cardiologist will monitor these medications closely as the child’s
clinical status evolves over time.15,16 Most interstage patients are
also on some form of antithrombotic therapy to ensure that the
ductal stent, Blalock-Taussig-Thomas shunt, or Sano remains
patent. Antithrombotic agents vary and typically include aspirin,
clopidogrel, and enoxaparin.
Immunisations
Infants with single ventricle CHD are eligible for palivizumab.
In addition, most centres advocate that infants receive their
2- and 4-month immunisations per scheduled guidelines as recent
evidence demonstrated that vaccine titers were not significantly
affected by cardiopulmonary bypass.16
Neurodevelopmental Evaluation
Ideally, infants with single ventricle heart disease are enrolled in an
Early Intervention Program at the time of initial hospital discharge
and are seen in a dedicated Neurodevelopment Clinic at least
once prior to their next cardiac surgery.17 Understanding of neurodevelopmental outcomes for these patients is rapidly evolving;
neurodevelopment concerns and delays are related to both the
underlying CHD as well as the myriad anaesthetic episodes and
interventional procedures they undergo in early life during critical
periods. Over their lifetime, patients may struggle with cognitive
impairment, impaired social interaction, inattention, impulsive
behaviours and impaired executive function. Motor problems
are present in up to 42% of school age children who have undergone surgical intervention for heart disease in the first year of life.
18
In some cases, CHD may be a marker of an underlying genetic or
syndromic condition, further increasing the risk of disability.
Undergoing a thorough evaluation in a dedicated programme,
when possible, is especially important to establish a baseline and
ensure that these children receive appropriate services.19
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Cardiology Follow-up
Any concerning home monitoring data or issues noted at followup clinic visits may warrant hospital admission to ensure that systemic and pulmonary blood flow are adequate. Saturations below
75% can indicate inadequate pulmonary blood flow due to a problem with the ductal stent/Sano/Blalock-Taussig-Thomas shunt.
Conversely, higher than expected saturations (>90%) may be a
sign of pulmonary over-circulation or the development of aortic
coarctation. Additional testing, such as a cardiac catheterisation,
may be obtained if the team is concerned about oxygen saturations
or the adequacy of systemic or pulmonary blood flow.
A cardiac catheterisation is routinely performed prior to the
second surgical intervention to assess the pulmonary vascular
resistance. This is important because the Stage 2 operation –
discussed below – requires passive blood flow from the upper body
through the lungs for gas exchange. In addition, if a Norwood surgery was performed, the reconstructed aortic arch will be evaluated
to ensure there is no residual coarctation. This “pre-Glenn” cardiac
catheterisation is generally performed within a month of the second-stage operation, usually between 3 and 5 months of age
depending on the infant’s weight, oxygen saturations, gestational
age, and other clinical factors discussed above.

3. Stage 2: Glenn and Hemi-Fontan (superior cavopulmonary
anastomosis)
Stage 2 palliation involves anastomosing the superior caval vein to
the pulmonary artery, technically known as a superior cavopulmonary anastomosis. Two variations of this procedure are common,
the bidirectional Glenn which involves direct end-to-side connection of the superior caval vein to the pulmonary artery (Fig 3) and
the hemi-Fontan, which involves a more complex connection of
the superior caval vein and pulmonary artery; the hemi-Fontan
is typically done at institutions that subsequently perform intracardiac (i.e., lateral tunnel) Fontan procedures (discussed below).
In addition, the ductal stent/Blalock-Taussig-Thomas shunt/
Sano/pulmonary artery band is removed if present. Pulmonary
blood flow is now entirely passive from the superior caval vein
through the pulmonary arteries. This passive flow requires low pulmonary vascular resistance and is the primary reason for waiting
until ~ 3–5 months of age to perform the Stage 2, since the pulmonary vascular resistance typically reaches its nadir after the first few
months of life. In fact, the high pulmonary vascular resistance in
the newborn period would not allow for effective Glenn flow,
which is why ductal stents, Blalock-Taussig-Thomas shunts, or
pulmonary artery bands are initially used to secure stable pulmonary flow in children with adequate systemic flow.
One important point is that Stage 2 circulation is more stable than
after initial palliation because the pulmonary and systemic circulations are separated, resulting in a lower burden on the single ventricle
which is dedicated to the systemic circulation. As a result, most infants
require a shorter post-operative hospital stay following this second
stage operation and families usually return the scales and other monitoring devices since the infants no longer require “interstage” home
monitoring. Oxygen saturations are usually in the 80% range immediately after the operation, though typically slowly decrease over time.
One important consideration is that the second stage circulation is
“preload-dependent,” so oxygen saturations may decrease in the setting of dehydration. Children with this physiology need special monitoring if they develop a gastrointestinal illness with significant
vomiting and/or diarrhoea.
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Activity restrictions
No specific activity limitations are indicated after sternal precautions have been lifted. Given the ages of patients in this stage
(i.e., ~6 months to ~ 3–5 years), these children will tend to limit
themselves as necessary.
Neurodevelopment evaluation
Infants and toddlers with Stage 2 circulation should continue to be
seen by early intervention and neurodevelopment teams to ensure
their development is appropriately supported.

Figure 3. Glenn operation diagram.
Stage II Glenn operation depicting the superior caval vein (SVC) anastomosis to the
right pulmonary artery (RPA) with flow going into both the RPA and left pulmonary
artery (LPA). The main pulmonary artery (MPA) is oversewn and the right atrium
(RA) no longer connected to the SVC.

Sternal Precautions and Wound Care
Post-operative issues are fairly standard after open-heart surgery
and generally do not depend on the specific operation. As such,
these issues are handled similar to after the first intervention.
Medications including Antithrombotics
Similar to after the first intervention, most are on some form of
antithrombotic agent to prevent thrombus development in the cavopulmonary pathway. Aspirin is commonly utilised, with clopidogrel and enoxaparin prescribed frequently by many centres as
well. Similarly, angiotensin-converting enzyme inhibitors, digoxin,
sildenafil, beta-blockers, and diuretics may be used if certain other
conditions are present. Again, the cardiologist will prescribe and
adjust these medications as needed. As discussed above, given
the pre-load dependence of the Stage 2 circulation, attention
should be paid to children on diuretics who develop a gastrointestinal illness as the medication may need to be held temporarily.
Immunisations
Infants with Stage 2 palliation are recommended to receive 6- and
12-month immunisations as scheduled per guidelines. Most
centres also strongly recommend the influenza vaccine when
appropriate. In addition, depending upon age and time of year,
these patients are also eligible for palivizumab.
Dental care and subacute bacterial endocarditis prophylaxis
Toddlers with single ventricle heart disease are recommended
to visit a paediatric dentist for an initial visit at approximately
12–18 months of age as recommended by the American
Academy of Pediatrics.20 Spontaneous bacterial endocarditis prophylaxis is indicated for dental procedures, given the presence of
“repaired” CHD with a residual shunt.21
School/daycare
Infants and young children with single ventricle heart disease are
generally safe to attend daycare once discharged from the hospital
and feeling well. This decision should be reviewed with the cardiologist on a case-by-case basis given the increased likelihood of respiratory and other infections in those settings. In addition, each
daycare centre has unique requirements and experience caring
for children with CHD so engaging with the centre as early as
possible may facilitate attendance.
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Cardiology follow-up
Patients are usually seen a few weeks after discharge to ensure they
are recovering from surgery adequately and oxygen saturations are
appropriate. The regularity of follow-up is then based on overall
clinical status, co-morbidities, and presence of residual cardiac
defects. Typically, after a good surgical outcome in a patient with
few other major conditions, the child is seen a few months after
surgery, then ultimately spaced out to every 6 months. Families
often miss the frequency of visits they had during the interstage
period, specifically the intensive emotional, medical, and behavioural support.9,22 However, the patients and families soon appreciate that fewer visits are a sign of a more stable child and enjoy the
time spent out of the hospital and doctors’ offices.
4. Stage-3: Fontan Operation (inferior cavopulmonary
anastomosis)
The Fontan operation is the third and final stage of single ventricle
palliation. This operation is called the inferior cavopulmonary
anastomosis and, as the name implies, involves connecting the
venous blood from the IVC/hepatic veins to the pulmonary circulation. The surgery is usually performed between 3 and 5 years of
age, based on centre preference. Timing may also be influenced by
oxygen saturations, exercise capacity, or other symptoms. Like the
Stage 2, most patients undergo a pre-Fontan cardiac catheterisation to reevaluate the anatomy and pulmonary vascular resistance,
ensuring that additional passive pulmonary blood flow from the
lower half of the body will be well tolerated.
The Fontan operation is currently performed with one of two
variations, either extracardiac or intracardiac (i.e., lateral tunnel).
In addition, many centres “fenestrate” the Fontan by creating a
small communication between the Fontan circuit and atrium.
This fenestration decompresses the Fontan circuit, by providing
a route for systemic venous blood to bypass the lungs (i.e., a
right-to-left shunt) if the pulmonary resistance is temporarily high
(e.g., immediately after surgery, during periods of respiratory illness). This decompression prevents sluggish flow and high venous
pressures in the Fontan, thereby improving circulation overall. The
pulmonary and systemic circulations are fully separated after the
Fontan, so oxygen saturations can be in the upper 90% range with
no fenestration and in the mid-80 to 90% range if fenestrated
(Fig 4).
Post-operative hospital length of stay varies, primarily related to
pleural drain output. Some Fontan patients have significant pleural
drain output that takes days-to-weeks to clear, leading to a delay in
tube removal. In fact, some centres may discharge patients with
chest tubes if the output persists.23 Occasionally, pleural effusions
re-accumulate after discharge, so primary paediatric providers
should observe for increased respiratory effort, decreased breath
sounds, and change in oxygen saturations. If any of these are

Cardiology in the Young

1551

many centres recommend spontaneous bacterial endocarditis
prophylaxis for all Fontan patients.
School/daycare
Similar to the Stage 2 patients, children with Fontan circulation are
safe to return to daycare or kindergarten once discharged from the
hospital and feeling well. Given the differing requirements and
experience among educational centres, paediatricians are encouraged to communicate the issues and needs of the child as soon as
possible.

Figure 4. Fontan operation with fenestration diagram.
Stage III Fontan operation depicting the extracardiac Fontan conduit which brings the
inferior caval vein blood up to the pulmonary arteries. Many centres will place a fenestration (i.e. “windowed”) shown here between the conduit and the right atrium (RA).
RV = right ventricle, LA = left atrium.

present, consider a chest X-ray and prompt call to the primary
cardiologist.
Sternal precautions and wound care
As noted above, post-operative issues are standard after open-heart
surgery and generally do not depend on the specific operation.
So, these restrictions will be handled like the first- and second-stage
palliations.
Medications including antithrombotics
Like prior stages, most patients are maintained on some form of
antithrombotic to prevent thrombus formation in the Fontan pathway. Typical agents include aspirin, clopidogrel, and even warfarin.
Special consideration is typically given to patients with a patent
fenestration as well as for 6 months after fenestration device closure since they are at higher risk for a systemic (a.k.a. “paradoxic”)
embolism. Similarly, angiotensin-converting enzyme inhibitors,
digoxin, sildenafil, beta-blockers, and diuretics may be used if certain other conditions are present. Over time, some patients develop
significant ventricular dysfunction requiring additional heart failure medication. Again, the cardiologist will follow and adjust these
medications as needed.
Vaccines
Children with Fontan circulation are recommended to receive all
appropriate immunisations, per the Centers for Disease Control
and Prevention schedule. Most centres also strongly recommend
the influenza vaccine when appropriate. Data on the safety and
efficacy of the COVID-19 vaccine do not exist in this population,
so please refer to Centers for Disease Control and Prevention
guidelines when available.
Dental care and subacute bacterial endocarditis prophylaxis
Excellent dental hygiene is important for these patients. Patients are
recommended to visit a dentist every 6 months. As with the Stage 2
patients, spontaneous bacterial endocarditis prophylaxis is indicated
for any patients with residual shunting (e.g., fenestration). In fact,
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Activity restrictions
Once sternal precautions have been lifted, many cardiologists
advise no activity limitations, as patients will typically limit themselves as necessary. Some cardiologists restrict from specific sports
based on exercise stress testing or other cardiac test results. Many
cardiologists reinforce the benefits of exercise, especially aerobic
exercise, given the crucial interaction between pulmonary blood
flow and general lung health. Depending on the needs and ongoing
issues, some patients may also benefit from referral to a dedicated
cardiac rehabilitation program24 if available.
Neurodevelopment evaluation
Ongoing neurodevelopmental evaluation is recommended by both
the American Academy of Pediatrics and American Heart
Association.17 Many centres refer according to those recommendations and evaluate all patients routinely at 4–5 years of age and then
again at 11–12 years of age, with additional visits as indicated. Many
school-age children benefit from an Individualized Education Plan
under the Individuals with Disabilities Education Act, as studies show
that children with CHD often have a higher rates of language, cognitive, and attentional difficulties.25,26
Cardiology follow-up
Patients are usually seen a few weeks after discharge to assess overall
clinical condition and monitor for recurrence of pleural effusions.
Subsequent cardiology visits are often spaced to every 6 months
for a few visits and then yearly if the patient is clinically well with
normal cardiac function. If a fenestration was placed, many centres
perform a cardiac catheterisation one year post-Fontan to evaluate
the Fontan circulation and determine if the fenestration can closed
percutaneously. In addition, a growing number of centres are developing multi-disciplinary Fontan clinics to address the non-cardiac
consequences of Fontan physiology.26,27
Long-term considerations
Though the staged palliation of single ventricle heart disease has
significantly improved the quality and length of single ventricle
patients’ lives, numerous longterm issues arise.28 For this reason,
many centres have multi-disciplinary care clinics for ongoing care
of Fontan circulation patients. A detailed review is beyond the
scope of this document, but some of the more common significant
issues affect the lungs, gastrointestinal tract, and liver as well as
mental health.
A major pulmonary complication is plastic bronchitis, a respiratory condition that occurs due to proteinaceous material that
accumulates in the lungs. It is marked by a productive cough without evidence of an infection (though super infections can develop),
so be aware if patients develop chronic cough. Some patients may
cough up “casts” of their bronchial tree. Plastic bronchitis is often
an insidiously progressive condition and can be lethal. Many
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centres consider the development of plastic bronchitis to be an
indication to list for heart transplantation.
Gastrointestinal complications include protein-losing enteropathy and hepatic disorders. Protein-losing enteropathy is a gastrointestinal issue that is marked by protein loss in stool. As expected,
this typically presents with oedema/ascites and diarrhoea. Like
plastic bronchitis, the natural history of protein-losing enteropathy
is often associated with a poor long-term prognosis so some centres
similarly consider it to be an indication to list for heart transplantation. From a liver standpoint, all Fontan patients are at risk of
developing cirrhosis related to elevated hepatic venous pressures
and congestion intrinsic to the Fontan circulation. Along those
lines, Fontan patients are at increased risk of developing hepatocellular carcinoma.
Patient mental health is a field with emerging knowledge.
Numerous recent studies have evaluated the long-term mental
health and quality of life of patients with Fontan physiology.29
Fontan patients are at risk for developing depression, anxiety,
and attention deficit disorder so routine mental health screening
is indicated.30
Last, though the 2nd and 3rd stages of single ventricle palliation
separated the circulations so that the single ventricle is only pumping to the body directly, the overall workload on the heart is still
increased because it has to drive the passive flow to the lungs.
As a result, Fontan patients often develop significant cardiac dysfunction and a fair number ultimately require heart transplant.28
Patients are also at risk of developing arrhythmias so routine evaluation is indicated. Long term there is evidence that lateral tunnel
(intracardiac) Fontan patients have a higher arrhythmia burden.
Conclusions
Patients with single ventricle CHD are complex and include a spectrum of various anatomic lesions. They represent a vulnerable
patient population as they undergo several procedures in infancy
and early childhood, spending significant time in the hospital and
clinics. As a result, patients and their families also shoulder a heavy
burden of stress and anxiety. Free and open communication
between their primary paediatric provider and cardiologist will
achieve better coordinated care. Regular, multi-disciplinary care
with the paediatrician at the helm of the child’s medical home is
the bedrock to maintain the health and wellness of these children.
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